These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29796276)

  • 1. Successful treatment by tolvaptan of the syndrome of inappropriate antidiuretic hormone secretion that may be associated with chemotherapy-induced tumour lysis in a patient with small-cell lung carcinoma.
    Miyashita K; Matsuura S; Naoi H; Tsukui M; Koshimizu N; Suda T
    Respirol Case Rep; 2018 Apr; 6(3):e00296. PubMed ID: 29796276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: Secondary failure to tolvaptan in a patient with SCLC and paraneoplastic SIADH.
    Menzi S; Jaramillo SD; Pfister S; Schefer H; Jehle AW
    Front Endocrinol (Lausanne); 2024; 15():1382066. PubMed ID: 38803472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolvaptan corrects hyponatremia and relieves the burden of fluid/dietary restriction and hospitalization in hyponatremic patients with terminal lung cancer: a report of two cases.
    Kai K; Tominaga N; Koitabashi K; Ichikawa D; Shibagaki Y
    CEN Case Rep; 2019 May; 8(2):112-118. PubMed ID: 30637666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan.
    Petereit C; Zaba O; Teber I; Lüders H; Grohé C
    BMC Pulm Med; 2013 Aug; 13():55. PubMed ID: 23987478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
    Estilo A; McCormick L; Rahman M
    Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syndrome of inappropriate antidiuretic hormone associated with chemotherapy-induced tumour lysis in small-cell lung cancer: case report and literature review.
    Vanhees SL; Paridaens R; Vansteenkiste JF
    Ann Oncol; 2000 Aug; 11(8):1061-5. PubMed ID: 11038047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of tolvaptan for the treatment of hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion in Sweden.
    Jamookeeah C; Robinson P; O'Reilly K; Lundberg J; Gisby M; Ländin M; Skov J; Trueman D
    BMC Endocr Disord; 2016 May; 16(1):22. PubMed ID: 27184496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
    Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Serum Sodium Levels during Chemotherapy Using Selective Arginine Vasopressin V2-Receptor Antagonist Tolvaptan in a Four-Year-Old Girl with a Suprasellar Germ Cell Tumor.
    Hiroshima S; Nyuzuki H; Sasaki S; Ogawa Y; Nagasaki K
    Children (Basel); 2021 Apr; 8(4):. PubMed ID: 33920088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of tolvaptan in an infant with syndrome of inappropriate antidiuretic hormone secretion associated with holoprosencephaly: A case report.
    Mori M; Takeshita S; Nakamura N; Mizuno Y; Tomita A; Aoyama M; Kakita H; Yamada Y
    World J Clin Cases; 2023 Sep; 11(26):6262-6267. PubMed ID: 37731562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tolvaptan in managing hyponatremia in small cell lung cancer patients with SIADH: a retrospective study of 23 cases.
    Ren P; Yang Q
    Transl Cancer Res; 2021 Mar; 10(3):1229-1237. PubMed ID: 35116450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective study on tolvaptan prescription in clinical practice in patients with syndrome of inappropriate secretion of antidiuretic hormone (SIADH) using the Japanese claims database.
    Hagiwara D; Matsukawa M; Tasaki J; Nakamura Y; Arima H
    Endocr J; 2023 Dec; 70(12):1195-1205. PubMed ID: 37914256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
    Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
    Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolvaptan for Treatment of Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) in a Child with Corpus Callosum Agenesis.
    Meena AK; Nanda PM; Sharma R; Chakrabarty B; Gulati S
    Indian J Pediatr; 2024 Feb; 91(2):188-190. PubMed ID: 36757652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tolvaptan on hyponatremia in a dog with syndrome of inappropriate secretion of antidiuretic hormone.
    Yamamoto H; Kimura K; Horikirizono H; Tamura Y; Kambayashi S; Baba K; Okuda M; Mizuno T; Igase M
    J Vet Med Sci; 2023 Oct; 85(10):1047-1051. PubMed ID: 37587049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.
    Verbalis JG; Greenberg A; Burst V; Haymann JP; Johannsson G; Peri A; Poch E; Chiodo JA; Dave J
    Am J Med; 2016 May; 129(5):537.e9-537.e23. PubMed ID: 26584969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syndrome of inappropriate secretion of anti-diuretic hormone due to hypothalamic hamartoma: use of tolvaptan.
    Moon RJ; Soliman M; Hoogenboom L; Gilbert RD; Bird-Lieberman G; Singh J; Bockenhauer D; Kumaran A
    J Pediatr Endocrinol Metab; 2023 Sep; 36(9):895-899. PubMed ID: 37327191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of SIADH due to pancreatic cancer was improved by tolvaptan].
    Matsuyama S; Ueo T; Ozawa T; Matsumoto A; Minami R; Kimura Y; Takeda Y; Okano A; Kusumi F; Ohana M
    Nihon Shokakibyo Gakkai Zasshi; 2022; 119(2):172-178. PubMed ID: 35153267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open-label, multicenter, dose-titration study to determine the efficacy and safety of tolvaptan in Japanese patients with hyponatremia secondary to syndrome of inappropriate secretion of antidiuretic hormone.
    Arima H; Goto K; Motozawa T; Mouri M; Watanabe R; Hirano T; Ishikawa SE
    Endocr J; 2021 Jan; 68(1):17-29. PubMed ID: 32863282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolvaptan for SIADH in Myelodysplastic Syndrome with Blast Crisis.
    Mali P; Muduganti SR; Mujibur R; Murali N
    WMJ; 2015 Apr; 114(2):66-8. PubMed ID: 26756059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.